‘We Believe We Have The Most Valuable Biosimilars Pipeline’ – Alvotech CEO Wessman On The Path Ahead

Chief Executive Talks Strategy, Pipeline, Products And Partnerships

 
• By Dave Wallace
  
Alvotech CEO Róbert Wessman talks to Generics Bulletin (Alvotech)

More from Generics Bulletin

More from Interviews